Yahoo News |
EU regulator backs approval for GSK injectable asthma drug
Yahoo News The treatment could help boost GSK's respiratory drugs business as demand weakens for its asthma drug, Advair. A significant minority of asthma patients do not respond to regular inhalers such as Advair, Dulera and Flovent, creating what analysts … Glaxo asthma drug clears key hurdle in Europe CHMP Backs Mepolizumab for Severe Eosinophilic Asthma GlaxoSmithKline's asthma injection heads for EU approval |
View full post on asthma – Google News